JEANETTE HAUPTMAN: Open Payments
NPI 1154575124 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 20 payments from 12 companies in 2025. Trend: 2023 $576 · 2024 $393 · 2025 $457
Food & beverage: $358Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| PFIZER INC. | 3 | $50 |
| ABBVIE INC. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Gilead Sciences, Inc. | 1 | $25 |
| Radius Health, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Organon LLC | 1 | $17 |
Products named: CAPLYTA, PREVNAR 20, UBRELVY, SPRAVATO, Veozah, Tymlos, INSPIRE, NEXPLANON.
Industry payments across NE — which companies pay providers there.
